Cesar Perez

4PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.

|Apr 11, 2024
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.

Benjamin Garmezy, Mitesh J Borad, Rastilav Bahleda

|Jun 20, 2023
Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.

Alison E Smith, Stacia Chan, Zhiyong Wang

|May 02, 2020
Ethical surgical triage of patients with head and neck cancer during the COVID-19 pandemic.

Francisco J Civantos, Jason M Leibowitz, David J Arnold

Pageof 1

Frequent Collaborators

1 joint publications

Alison E Smith

1 joint publications

Stacia Chan

1 joint publications

Zhiyong Wang

1 joint publications

Asako McCloskey